Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Trump rolls back Biden directive to study methods of lowering prescription costs

by
January 21, 2025
in Health Care
0
Trump rolls back Biden directive to study methods of lowering prescription costs

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for Medicare and Medicaid beneficiaries.

Trump rescinded former President Biden’s Executive Order 14087, “Lowering Prescription Drug Costs for Americans.” He included this directive among those he deemed to be “unpopular, inflationary, illegal, and radical practices.”

Biden’s executive order asked the Health and Human Services (HHS) secretary to look into “new health care payment and delivery models that would lower drug costs and promote access to innovative drug therapies for beneficiaries enrolled in the Medicare and Medicaid programs.”

The secretary could include models “that may lead to lower cost-sharing for commonly used drugs and support value-based payment that promotes high-quality care.” This executive order was meant to complement and build off of the health care cost provisions included in the Inflation Reduction Act (IRA).

The Centers for Medicare and Medicaid Services (CMS) did explore payment models in respect to this order, publishing a report of its findings in 2023.

Among the models that were looked into, then-HHS Secretary Xavier Becerra chose one that would have allowed Medicare Part D sponsors to offer a “Medicare-defined standard set of approximately 150 high-value generic drugs with a maximum co-payment of $2 for a month’s supply.”

HHS also looked into a system that would have incentivized manufacturers to “expedite and complete confirmatory clinical trials” and have CMS develop for drugs approved under accelerated approval.

This method would have theoretically reduced CMS spending on clinical confirmatory trials that missed their completion date. At the time of report, it was noted about a third of drugs approved through the accelerated approval process had incomplete confirmatory trials.

Another model HHS proposed for testing on looked into whether CMS could coordinate multi-state outcomes-based agreements (OBA) with manufacturers of high-cost specialty drug, instead of having state Medicaid agencies pursue individual OBAs. This would have reduced costs by in theory pooling “bargaining power to obtain discounted pricing.”

While these models were explored, they ultimately were not put into action during the Biden administration.

Several Biden-era provisions aimed at lowering prescription costs for Medicare beneficiaries will be going into effect throughout Trump’s second term. The IRA provision limiting Medicare out-of-pocket spending on prescription drugs to $2,000 went into effect at the start of this year.

The lowered prices of the first 10 drugs picked for Medicare negotiations will go into effect at the start of 2026 and the Medicare rebate program yielded temporary savings on dozens of prescriptions last year.

Previous Post

WHO defends global health, security role after Trump withdrawal

Next Post

FDA approves standalone use of J&J’s ketamine-derived depression treatment

Next Post
FDA approves standalone use of J&J’s ketamine-derived depression treatment

FDA approves standalone use of J&J’s ketamine-derived depression treatment

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025
    Bird flu can live in raw milk for more than a week, study finds

    Bird flu can live in raw milk for more than a week, study finds

    June 6, 2025

    Trending

    Reproductive health group, ACLU sue Trump administration over Title X funding

    Reproductive health group, ACLU sue Trump administration over Title X funding

    April 25, 2025
    Fewer than half of U.S. jails provide medications for opioid use disorder

    Fewer than half of U.S. jails provide medications for opioid use disorder

    September 24, 2024
    Brain fog a reality for some post-COVID patients

    Brain fog a reality for some post-COVID patients

    June 4, 2022
    Americans with poor diet fall from 49 percent to 37 percent: Study

    Americans with poor diet fall from 49 percent to 37 percent: Study

    June 18, 2024

    Recent News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025

    Popular News

    • A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges
    • Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.